These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 563433)

  • 41. Border disease of sheep: isolation of the virus in tissue culture and experimental reproduction of the disease.
    Harkness JW; King AA; Terlecki S; Sands JJ
    Vet Rec; 1977 Jan; 100(4):71-2. PubMed ID: 402050
    [No Abstract]   [Full Text] [Related]  

  • 42. Experimental Border disease in sheep: dose-response effect.
    Richardson C; Hebert CN; Done JT
    Br Vet J; 1976; 132(2):202-8. PubMed ID: 963500
    [No Abstract]   [Full Text] [Related]  

  • 43. [Antibodies to myelin cerebrosides and their role in the pathogenesis of autoimmune demyelinating diseases (review)].
    Taranova NP; Kirchik OS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(12):1863-72. PubMed ID: 3911691
    [No Abstract]   [Full Text] [Related]  

  • 44. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.
    Koski CL; Sanders ME; Swoveland PT; Lawley TJ; Shin ML; Frank MM; Joiner KA
    J Clin Invest; 1987 Nov; 80(5):1492-7. PubMed ID: 3680509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Border disease of sheep: the diagnostic significance of medullated wool fibre scores and counts of glial cells in the spinal cord.
    Barlow RM
    Res Vet Sci; 1972 May; 13(3):236-40. PubMed ID: 5043125
    [No Abstract]   [Full Text] [Related]  

  • 46. The nature of factors in chronic relapsing EAE and MS sera which induce myelinotoxicity and cellular changes in organ culture.
    Bradbury K; Suckling AJ
    Prog Clin Biol Res; 1984; 146():193-8. PubMed ID: 6201890
    [No Abstract]   [Full Text] [Related]  

  • 47. Border disease: a sequential study of surviving lambs and an assessment of its effect on profitability.
    Sweasey D; Patterson DS; Richardson C; Harkness JW; Shaw IG; Williams WW
    Vet Rec; 1979 May; 104(20):447-50. PubMed ID: 473556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Observations on the histology and possible pathogenesis of lesions in the central nervous system of sheep with swayback.
    Howell JM
    Proc Nutr Soc; 1968 Mar; 27(1):85-8. PubMed ID: 5748757
    [No Abstract]   [Full Text] [Related]  

  • 49. Indication of a possible role in a demyelinating neuropathy for an antigen shared between myelin and NK cells.
    Murray N; Steck AJ
    Lancet; 1984 Mar; 1(8379):711-3. PubMed ID: 6200739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Periarteritis in experimental Border disease of sheep. II. Morphology and histochemistry of the lesion.
    Zakarian B; Barlow RM; Rennie JC; Head KW
    J Comp Pathol; 1976 Jul; 86(3):477-87. PubMed ID: 7578
    [No Abstract]   [Full Text] [Related]  

  • 51. Induction of anti-myelin antibodies in EAE and their possible role in demyelination.
    Sadler RH; Sommer MA; Forno LS; Smith ME
    J Neurosci Res; 1991 Dec; 30(4):616-24. PubMed ID: 1787538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice.
    Welsh CJ; Tonks P; Nash AA; Blakemore WF
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1659-67. PubMed ID: 2953860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The jimpy mouse].
    Robain O
    Acta Zool Pathol Antverp; 1977 Aug; (68):68-92. PubMed ID: 920554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myelin-associated glycoprotein in development and disease.
    Quarles RH
    Dev Neurosci; 1983-1984; 6(6):285-303. PubMed ID: 6085570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early morphological and histochemical consequences of peripheral nerve section in lambs of normal and low copper status.
    Barlow RM
    J Pathol; 1969 Oct; 99(2):153-62. PubMed ID: 4311877
    [No Abstract]   [Full Text] [Related]  

  • 56. Recent advances in border disease.
    Barlow RM; Gardiner AC; Rennie JC; Keir WA; Storey IJ
    J Pathol; 1972 Jul; 107(3):Pvii. PubMed ID: 5084951
    [No Abstract]   [Full Text] [Related]  

  • 57. Experiments in Border disease: X. The postnatal skin lesion in sheep and goats.
    Orr MB; Barlow RM
    J Comp Pathol; 1978 Apr; 88(2):295-302. PubMed ID: 659682
    [No Abstract]   [Full Text] [Related]  

  • 58. Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma.
    Rosenbluth J; Schiff R; Liang WL; Dou W
    J Neurocytol; 2003 Mar; 32(3):265-76. PubMed ID: 14724389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal IgM-associated demyelinating peripheral neuropathy: an expression of monoclonal autoimmunity.
    Marmont AM; Mancardi GL; Tabaton M; Siccardi M; Grassia L; Schenone A; Repetto M
    Haematologica; 1985; 70(6):471-6. PubMed ID: 2420687
    [No Abstract]   [Full Text] [Related]  

  • 60. Early myelin lesions in experimental allergic neuritis.
    Rosen JL; Brown MJ; Hickey WF; Rostami A
    Muscle Nerve; 1990 Jul; 13(7):629-36. PubMed ID: 2388663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.